4th Quarter - Report

FORBES-TATE for SPERO THERAPEUTICS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to biopharmaceutical research, development and commercialization.

LobbyistCovered position, as disclosed
PAUL DIOGUARDI —
ELIZABETH GREER —
BARRETT THORNHILL —
ZACHARY WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.